Proteins associated with the regulation of organ size and shape have been found to respond to the mechanics of the microenvironment in ways that specifically affect the decision of adult cardiac stem cells to generate muscular or vascular cells.
Cell development for specific functions — so-called cell differentiation — is crucial for maintaining healthy tissue and organs. Two proteins in particular — the Yes-associated protein (YAP) and WW domain-containing transcription regulator protein 1 (WWTR1 or TAZ) — have been linked with control of cell differentiation in the tissues of the lymphatic, circulatory, intestinal and neural systems, as well as regulating embryonic stem cell renewal.
An international collaboration of researchers has now identified that changes in the elasticity and nanotopography of the cellular environment of these proteins can affect how heart stem cells differentiate with implications for the onset of heart diseases.
Researchers at the International Center for Materials Nanoarchitectonics (MANA), National Institute for Materials Science (NIMS) collaborated with researchers in Finland, Italy, the Netherlands, Saudi Arabia and the Czech Republic in the study.
They engineered YAP and TAZ proteins that expressed green fluorescent protein so that their location within the cell could be tracked. They then prepared cell substrates from smart biomaterials displaying dynamic control of elasticity and nanostructure with temperature.
“Our data provide the first evidence for YAP/TAZ shuttling activity between the nucleus and the cytoplasm being promptly activated in response to dynamic modifications in substrate stiffness or nanostructure,” explain the researchers.
Observations of gene expression highlighted the key role of YAP/TAZ proteins in cell differentiation. In further investigations on the effect of substrate stiffness they also found that cell differentiation was most efficient for substrates displaying stiffness similar to that found in the heart.
The authors suggest that understanding the effects of microenvironment nanostructure and mechanics on how these proteins affect cell differentiation could be used to aid processes that maintain a healthy heart.
They conclude, “These proteins are indicated as potential targets to control cardiac progenitor cell fate by materials design.”
International Center of Materials Nanoarchitectonics (MANA)
National Institute for Materials Science
1-1 Namiki Tsukuba, Ibaraki 305-0044 JAPAN
International Center for Materials Nanoarchitectonics (WPI-MANA)
Address: 1-1 Namiki, Tsukuba, Ibaraki 305-0044, Japan
Hippo pathway effectors control cardiac progenitor cell fate by acting as dynamic sensors of substrate mechanics and nanostructure. Diogo Mosqueira,1,2,† Stefania Pagliari,1,3,† Koichiro Uto,1 Mitsuhiro Ebara,1 Sara Romanazzo,1 Carmen Escobedo-Lucea,4 Jun Nakanishi,1 Akiyoshi Taniguchi,1 Ornella Franzese,5 Paolo Di Nardo,6 Marie Jose´ Goumans,7 Enrico Traversa,8 Perpetua Pinto-do-O,2 Takao Aoyagi,1,‡,* and Giancarlo Forte1,9,†,0* 2014 ACS NANO; DOI: 10.1021/nn4058984.
1. Biomaterials Unit, International Center for Materials Nanoarchitectonics (MANA), National Institute for Materials Science (NIMS), Tsukuba, Japan
2. Instituto de Engenharia Biomedica-INEB, Universidade do Porto, Porto, Portugal
3. Japan Society for the Promotion of Science (JSPS), Tokyo, Japan
4. Academy of Finland Research Fellow, Division of Pharmaceutical Biosciences/Center for Drug Research (CDR), University of Helsinki, Helsinki, Finland
5. Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy
6. Department of Clinical Sciences and Translational Medicine, University of Rome Tor Vergata, Rome, Italy
7. Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands
8. King Abdullah University of Science and Technology (KAUST), Thuwal, Saudi Arabia
9. International Clinical Research Center (ICRC), Integrated Center of Cellular Therapy and Regenerative Medicine, St. Anne's University Hospital, Brno, Czech Republic.
0. Present address: International Clinical Research Center (ICRC), Integrated Center of Cellular Therapy and Regenerative Medicine, St. Anne's University Hospital, Brno, Czech Republic.
†These authors contributed equally.
‡These authors contributed equally.
* Corresponding authors
Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University
The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy